Loading
Extracellular Vesicles in Disease / Inflammasome and Immune Disorders · Journal article
Next Nanotechnology · August 25, 2026
Raises a question worth testing. It does not answer one.
This is a comprehensive narrative review proposing that plant-derived exosome-like nanoparticles (PELNs) from TCM herbs may mediate antimicrobial efficacy through multiple mechanisms including membrane disruption, immunomodulation, and quorum-sensing inhibition. The review synthesizes preclinical evidence and identifies significant translational gaps (scalability, standardization, safety, regulatory classification) that must be resolved before clinical application.
Narrative review. Traditional Chinese medicine herbs and their isolated plant-derived exosome-like nanoparticles; no human or clinical population studied.
PELNs isolated from TCM plants (Zingiber officinale, Curcuma longa, Allium sativum, Camellia sinensis, Lonicera japonica) carry antimicrobial phytochemicals including gingerols, curcumin, allicin, and EGCG Compared with synthetic nanocarriers, PELNs demonstrate favourable biocompatibility, relatively low immunogenicity, and partial resistance to gastrointestinal degradation in experimental studies Antimicrobial mechanisms proposed include direct membrane disruption, toxin neutralization, phosphatidic acid-mediated selective bacterial uptake, cross-kingdom miRNA gene silencing, and quorum-sensing inhibition
Regulatory pathway and safety profile remain undefined; translational feasibility not established
This review does not report clinical evidence and should not guide clinical practice. It identifies a mechanistic hypothesis and framework for future translational research, but emphasizes that significant challenges in standardization, safety, and regulatory classification must be overcome before clinical application.
This is a narrative review synthesizing preclinical mechanistic evidence and proposing a theoretical framework; it does not report primary experimental data, clinical outcomes, or comparative efficacy studies.
As stated by the source record.
This review does not report clinical evidence and should not guide clinical practice. It identifies a mechanistic hypothesis and framework for future translational research, but emphasizes that significant challenges in standardization, safety, and regulatory classification must be overcome before clinical application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Traditional Chinese Medicine (TCM) has long employed herbs such as ginger (Sheng Jiang, 生姜), turmeric (Jiang Huang, 姜黄), garlic (Da Suan, 大蒜), ginseng (Ren Shen, 人参), licorice (Gan Cao, 甘草), green tea (Lü Cha, 绿茶), and honeysuckle (Jin Yin Hua, 金银花) in classical compound formulations including Yin Qiao San (银翘散), Si Junzi Tang (四君子汤), and Xiao Banxia Tang (小半夏汤) for the treatment of infectious diseases, inflammatory conditions, and gastrointestinal disorders. Emerging evidence now suggests that plant-derived exosome-like nanoparticles (PELNs), nanoscale membranous vesicles naturally produced by these medicinal plants, may constitute a previously unrecognized nanobiological mechanism that underlies and partially explains the therapeutic efficacy attributed to these herbs within the TCM pharmacological system. These nanovesicles, isolated from TCM source plants including Zingiber officinale, Curcuma longa, Allium sativum, Camellia sinensis, and Lonicera japonica, carry a complex cargo of lipids, proteins, plant-specific microRNAs, and potent antimicrobial phytochemicals including gingerols, curcumin, allicin, and epigallocatechin gallate (EGCG). Compared with many synthetic nanocarriers, PELNs have demonstrated favourable biocompatibility, relatively low immunogenicity, partial resistance to gastrointestinal degradation, and potential capability for cross-kingdom biological interactions in experimental studies. This comprehensive review systematically examines the biogenesis, structural architecture, and molecular composition of PELNs, with critical emphasis on their antimicrobial mechanisms including direct membrane disruption, toxin neutralization, phosphatidic acid-mediated selective bacterial uptake, cross-kingdom miRNA gene silencing, immunomodulation via the aryl hydrocarbon receptor pathway, and quorum-sensing inhibition for anti-biofilm applications. Engineering strategies for surface modification, drug co-loading, and pharmacokinetic optimization are evaluated within the context of TCM therapeutic principles. The potential relevance of PELNs in addressing antimicrobial resistance (AMR), particularly against multidrug-resistant pathogens, is critically discussed based on currently available preclinical evidence. Translational challenges encompassing scalability, standardization, stability, safety, and regulatory classification are discussed alongside emerging solutions. Overall, this review positions PELNs as a molecular bridge between classical TCM herbal pharmacology and modern nanomedicine, while emphasizing the significant mechanistic, translational, and regulatory challenges that must be addressed before clinical application.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.